R

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

By Rita Jermyn
8,801 views
April 12, 2022
Comments 1
Login to view comments. Click here to Login

Featured Video

05:05
Ardelyx

Learn More About a Different MOA to treat Hyperphosphatemia as Add o…

Featured Video

05:41
Ardelyx

Clinical Experience with a Hyperphosphatemia Treatment Option as Add…

Feat. S. Chillemi

Related Videos

National Jewish Health

Improving Cardiovascular Outcomes: The New Era of Prevention (Hybrid…

Thu, Jun 12, 2025
The American Society for Preventive Cardiology

ASPC Virtual Multimodality Cardiovascular Imaging for Prevention: Es…

Sat, Apr 5, 2025
See 1 other
47:11

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

74.8K views
64:45

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

48.9K views
49:21

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

26.8K views
11:37

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

24.5K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

23.9K views
18:43

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

12.5K views
23:35

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Practical Ways to Achieve Targets in Diabetes Care

I. Hirsch

12.4K views
37:21

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

11.9K views
12:26

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

12.2K views
15:06

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

9.2K views
26:01

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

9.6K views
27:24

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

9.1K views
26:49

Tirzepatide Updates

Diana Isaacs

8.8K views
15:33

Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a Safer…

Ken Fujioka

8.1K views
33:23

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

7.8K views
24:21

New

The Role of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Pediatr…

ISPAD's 50th Annual Conference 2024

A. Sanghavi

28 views
26:32

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

6.0K views
60:08

New

Therapeutic Strategies for Cardiovascular-Kidney Metabolic Syndrome:…

WCIRDC

J. Green, P. Taub, M. R. Weir

38 views
18:31

Difficult-to-Treat Type 2 Diabetes – Could Hypercortisolism be the E…

Endocrinology 2024 Year in Review

185 views
18:34

ECG Interpretation: Everything You Need to Know to Understand and In…

Houston Methodist DeBakey Heart and Vascular Center

A. Dave

6.6K views
AUTOPLAY